Baotou Dongbao Bio-Tech Co Ltd Strategic Asset Allocation Index
Baotou Dongbao Bio-Tech Co Ltd strategic asset allocation index. Baotou Dongbao Bio-Tech Co Ltd (300239) has a Strategic Asset Allocation Index of 59.1% as of June 2023. Strategic assets (PP&E of CN¥1.07 Billion plus long-term investments of CN¥-) total CN¥1.07 Billion, measured against net assets of CN¥1.81 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Baotou Dongbao Bio-Tech Co Ltd (300239) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Baotou Dongbao Bio-Tech Co Ltd (2008–2022)
Strategic asset allocation index of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2022. This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of June 2023, the index stands at 59.1%, representing strategic assets of CN¥1.07 Billion against net assets of CN¥1.81 Billion CNY.
Baotou Dongbao Bio-Tech Co Ltd Strategic Asset Allocation Index by Year (2008–2022)
Baotou Dongbao Bio-Tech Co Ltd strategic asset allocation index by year from 2008 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300239 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 58.0% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥1.76 Billion | ▼ -2.3 pp |
| 2021 | 60.3% | CN¥966.90 Million | CN¥966.90 Million | CN¥- | CN¥1.60 Billion | ▼ -21.1 pp |
| 2020 | 81.4% | CN¥812.04 Million | CN¥812.04 Million | CN¥- | CN¥998.18 Million | ▲ +6.5 pp |
| 2019 | 74.9% | CN¥742.71 Million | CN¥742.71 Million | CN¥- | CN¥991.86 Million | ▼ -11.1 pp |
| 2018 | 86.0% | CN¥645.47 Million | CN¥636.73 Million | CN¥8.74 Million | CN¥750.88 Million | ▲ +6.4 pp |
| 2017 | 79.6% | CN¥580.62 Million | CN¥574.81 Million | CN¥5.80 Million | CN¥729.75 Million | ▲ +20.4 pp |
| 2016 | 59.2% | CN¥425.56 Million | CN¥421.47 Million | CN¥4.09 Million | CN¥718.86 Million | ▲ +26.2 pp |
| 2015 | 33.0% | CN¥233.13 Million | CN¥233.13 Million | CN¥- | CN¥706.55 Million | ▼ -28.3 pp |
| 2014 | 61.3% | CN¥208.63 Million | CN¥208.63 Million | CN¥- | CN¥340.56 Million | ▼ -1.0 pp |
| 2013 | 62.3% | CN¥218.88 Million | CN¥218.88 Million | CN¥- | CN¥351.47 Million | ▼ -4.1 pp |
| 2012 | 66.4% | CN¥215.03 Million | CN¥215.03 Million | CN¥- | CN¥324.03 Million | ▲ +9.2 pp |
| 2011 | 57.2% | CN¥169.26 Million | CN¥169.26 Million | CN¥- | CN¥295.99 Million | ▼ -43.9 pp |
| 2010 | 101.1% | CN¥123.80 Million | CN¥123.80 Million | CN¥- | CN¥122.44 Million | ▼ -18.2 pp |
| 2009 | 119.3% | CN¥120.11 Million | CN¥120.11 Million | CN¥- | CN¥100.65 Million | ▲ +7.5 pp |
| 2008 | 111.8% | CN¥109.44 Million | CN¥109.44 Million | CN¥- | CN¥97.87 Million | — |